Bionano Genomics, Inc.
BNGO
$3.77
-$0.08-2.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.73M | 6.46M | 8.16M | 6.07M | 7.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.73M | 6.46M | 8.16M | 6.07M | 7.77M |
| Cost of Revenue | 3.26M | 3.52M | 4.75M | 14.52M | 5.19M |
| Gross Profit | 3.48M | 2.94M | 3.42M | -8.45M | 2.59M |
| SG&A Expenses | 8.35M | 9.03M | 856.00K | 9.46M | 11.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.53M | 14.92M | 9.08M | 28.70M | 23.57M |
| Operating Income | -7.80M | -8.47M | -913.00K | -22.63M | -15.80M |
| Income Before Tax | -6.85M | -3.10M | -20.12M | -44.22M | -16.20M |
| Income Tax Expenses | 10.00K | 7.00K | 1.00K | 24.00K | 26.00K |
| Earnings from Continuing Operations | -6.86M | -3.10M | -20.13M | -44.25M | -16.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.86M | -3.10M | -20.13M | -44.25M | -16.22M |
| EBIT | -7.80M | -8.47M | -913.00K | -22.63M | -15.80M |
| EBITDA | -5.37M | -5.98M | 1.33M | -16.95M | -12.76M |
| EPS Basic | -1.99 | -1.15 | -12.22 | -30.92 | -14.41 |
| Normalized Basic EPS | -1.24 | -0.72 | -2.17 | -10.02 | -10.52 |
| EPS Diluted | -1.99 | -1.15 | -12.22 | -30.92 | -14.41 |
| Normalized Diluted EPS | -1.24 | -0.72 | -2.17 | -10.02 | -10.52 |
| Average Basic Shares Outstanding | 3.44M | 2.69M | 1.65M | 1.43M | 1.13M |
| Average Diluted Shares Outstanding | 3.44M | 2.69M | 1.65M | 1.43M | 1.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |